Oral combination chemotherapy in conjunction with G-CSF [filgrastim] in the treatment of elderly patients with intermediate and high grade non-Hodgkin's lymphoma.

Trial Profile

Oral combination chemotherapy in conjunction with G-CSF [filgrastim] in the treatment of elderly patients with intermediate and high grade non-Hodgkin's lymphoma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Jan 2011

At a glance

  • Drugs Filgrastim (Primary) ; Cyclophosphamide; Etoposide; Lomustine; Procarbazine
  • Indications Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jan 2011 Planned End Date changed from 1 Feb 2015 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 14 Jan 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Mar 2010 Actual patient number (6) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top